Brady Corp.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: US1046741062
USD
77.95
-0.6 (-0.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Brady Corp. stock-summary
stock-summary
Brady Corp.
Miscellaneous
Brady Corporation is a manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. The Company has two segments: Identification Solutions (IDS) and Workplace Safety (WPS). The IDS segment includes identification and healthcare products, and the WPS segment includes workplace safety and compliance products. The IDS segment offers products that are manufactured under various brands, including the Brady brand, and are primarily sold through distribution to a range of maintenance, repair and operations (MRO) and original equipment manufacturing (OEM) customers, and through other channels. The WPS segment offers a range of product categories, such as safety and compliance signs, tags, and labels; informational and architectural signage; industrial warehouse and office equipment, and labor law compliance posters. Its brands include Electromark, Identicard, PromoVision, Scafftag, Seton and Emedco.
Company Coordinates stock-summary
Company Details
6555 W Good Hope Rd, PO Box 571 MILWAUKEE WI : 53201-0571
stock-summary
Tel: 1 414 3586600
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 77 Schemes (49.59%)

Foreign Institutions

Held by 133 Foreign Institutions (10.8%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Conrad Goodkind
Independent Chairman of the Board
Mr. J. Michael Nauman
President, Chief Executive Officer, Director
Dr. David Bem
Director
Dr. Michelle Williams
Director
Mr. Patrick Allender
Independent Director
Mr. Gary Balkema
Independent Director
Dr. Elizabeth Bruno
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
397 Million
(Quarterly Results - Jul 2025)
Net Profit:
50 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 4,028 Million (Small Cap)

stock-summary
P/E

18.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

59.46%

stock-summary
Debt Equity

-0.05

stock-summary
Return on Equity

15.87%

stock-summary
Price to Book

3.38